FUCALES DA

Closed at July 13th, 2023

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: WY
Wenche Ytreland1968
Operation time: 5 years; - Jun 5, 2018 to Jul 13, 2023
Type: General Partnership with shared liability
VAT registered: No
Number of employees: 0

Last update: Apr 13, 2023

Management

Management / administration

Name	Role	Shares
WY Wenche Ytreland 1968	Managing Director/CEO	-

Board

Name	Role	Shares
SV Svein Vindenes 1969 Resigned	Participant with Pro Rata Liability (Shared Liability)	-
WY Wenche Ytreland 1968	Participant with Pro Rata Liability (Shared Liability)	-

Last update: Apr 13, 2023

Ownership

No available data

Financials

in NOK

Summary

Year
Total operating income
Annual Total Result
Total assets
Total liabilities
Total equity

P&L

Year
Total operating income
Total operating costs
Operating result
Financial income/costs
Profit before tax
Total tax & extraordinary income/cost
Annual Total Result

Balance overview

Year
Total fixed assets
Total current assets
Total assets
Short term debt
Long term debt
Total liabilities
Contributed capital
Retained earnings
Total equity
Total equity and liabilities

Classification

21st company classification

BETA

Small company

FUCALES DA920 860 761